- Home
- PLUG vs TFX Comparison
PLUG vs TFX Comparison
Compare PLUG & TFX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PLUG | TFX |
|---|---|---|
| Founded | 1997 | 1943 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.1B | 4.6B |
| IPO Year | 1999 | 1994 |
Fundamental Metrics
Financial Performance| Metric | PLUG | TFX |
|---|---|---|
| Price | $3.11 | $121.97 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 11 | 8 |
| Target Price | $2.31 | ★ $138.75 |
| AVG Volume (30 Days) | ★ 68.5M | 871.7K |
| Earning Date | 05-11-2026 | 05-07-2026 |
| Dividend Yield | N/A | ★ 1.02% |
| EPS Growth | ★ 47.01 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $709,919,000.00 | ★ $1,992,713,000.00 |
| Revenue This Year | $26.67 | $15.97 |
| Revenue Next Year | $8.09 | $5.15 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ 12.90 | N/A |
| 52 Week Low | $0.69 | $100.18 |
| 52 Week High | $4.58 | $139.67 |
Technical Indicators
Market Signals| Indicator | PLUG | TFX |
|---|---|---|
| Relative Strength Index (RSI) | 57.88 | 45.77 |
| Support Level | $1.43 | $117.09 |
| Resistance Level | $4.58 | $126.13 |
| Average True Range (ATR) | 0.24 | 4.81 |
| MACD | -0.00 | -1.17 |
| Stochastic Oscillator | 52.41 | 6.28 |
Price Performance
Historical ComparisonAbout PLUG Plug Power Inc.
Plug Power Inc is building an end-to-end green hydrogen ecosystem, from production, storage, and delivery to energy generation. The company plans to build and operate green hydrogen highways across North America and Europe. Plug will deliver its green hydrogen solutions directly to its customers and through joint venture partners into multiple end markets, including material handling, e-mobility, power generation, and industrial applications.
About TFX Teleflex Incorporated
Teleflex is a Wayne, Pennsylvania-based manufacturer of hospital supplies and medical devices primarily in the bloodstream/vascular and surgical areas. The firm reports results across seven segments: vascular access (24% of 2024 sales), interventional (19%), anesthesia (13%), surgical (15%), interventional urology (11%), original-equipment manufacturing (11%), and other (7%). Geographic exposure for the business is primarily in the US, which accounts for 60% of revenue, with international markets making up the remainder.